Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Often described as ‘miracle’ cells, stem cells need to be truly mastered if we’re to use them in medical treatments.
TipRanks on MSN
Zimmer Biomet’s Study on Comprehensive Primary Revision Stems: A Market Game Changer?
Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. Study Overview: Zimmer Biomet Holdings is conducting a study ...
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is collaborating with World ...
A Delaware judge correctly interpreted transcatheter aortic valve-replacement device patents that were asserted against ...
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback